Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Mark, Love"'
Publikováno v:
JCO Global Oncology, Vol , Iss 10 (2024)
Bush et al emphasize that the key to establishing enduring and efficient global health systems lies in prioritizing local stakeholders and, above all, the welfare of patients.
Externí odkaz:
https://doaj.org/article/a285f8f34fa0448d94c53b9568e38684
Autor:
Mark Love, C. Beal, S. Pene, Rt. T. Rarokolutu, A. Whippy, S. Taivoce, S. Shrestha, R. T. Souter
Publikováno v:
Water Policy, Vol 25, Iss 1, Pp 38-58 (2023)
Pacific Island countries have among the lowest access to improved drinking water sources and sanitation services in the world. Due to geography, climate, the high frequency, and severity of disasters, transportation difficulties and resource constrai
Externí odkaz:
https://doaj.org/article/eb05cd18af1c49ae8c88e693c3f7afeb
Autor:
Mark Love, C. Beal, S. Pene, Rt. T. Rarokolutu, A. Whippy, S. Taivoce, S. Shrestha, R. T. Souter
Publikováno v:
Water Policy. 25:38-58
Pacific Island countries have among the lowest access to improved drinking water sources and sanitation services in the world. Due to geography, climate, the high frequency, and severity of disasters, transportation difficulties and resource constrai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9e0b63bc54960d91d7028023a62127d6
https://doi.org/10.2166/wp.2022.202
https://doi.org/10.2166/wp.2022.202
Autor:
Mark A. Taylor, Thomas McKaig, Mark Love, Heather Nesbitt, Jinhui Gao, Bridgeen Callan, Anthony P. McHale, John F. Callan, Keiran Logan
Publikováno v:
European Journal of Pharmaceutics and Biopharmaceutics. 165:374-382
Gemcitabine and nab-paclitaxel (Abraxane®) is a standard of care chemotherapy combination used in the treatment of patients with advanced pancreatic cancer. While the combination has shown a survival benefit when compared to gemcitabine monotherapy,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8aa72f497cb8c059963c3bfa82d31bb5
https://doi.org/10.1016/j.ejpb.2021.05.018
https://doi.org/10.1016/j.ejpb.2021.05.018
Autor:
Joseph Doyle, Nadiah Latip, Stephen McCain, Ryan Scott, Mark Love, Mark Taylor, David Vass, Claire Jones, Gareth Kirk, Lloyd McKie, Thomas Diamond
Publikováno v:
British Journal of Surgery. 108
Background This was a consecutive case-series of all pancreatic fluid collections (PFCs) managed with AXIOS™ stents in a 3 year period from a single healthcare trust, retrospectively analysed to determine the rate of technical success, clinical suc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cde679022c1834d38d23370a38b2c450
https://doi.org/10.1093/bjs/znab430.258
https://doi.org/10.1093/bjs/znab430.258
Autor:
Heather Nesbitt, Keiran Logan, Keith Thomas, Bridgeen Callan, Jinhui Gao, Thomas Mc Kaig, Mark Taylor, Mark Love, Eleanor Stride, Anthony Mc Hale, John Callan
Publikováno v:
British Journal of Surgery. 108
Background The emergence of immune checkpoint inhibitors (ICI’s) in the past decade has proven transformative in the area of immuno-oncology. The PD-1 / PD-L1 axis has been particularly well studied and monoclonal antibodies developed to block eith
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::324765eab9153b2269b7b7824c477e4c
https://doi.org/10.1093/bjs/znab429.045
https://doi.org/10.1093/bjs/znab429.045
Autor:
Robert J Norgard, Pratha Budhani, Sarah O'Brian, Jessica Potts, Brianna Flynn, Xavier Salce, Joshua Tagore, Lucinda Thiede, Joseph Seco, Suzanne Segal, Mark Love, Ania Mikucka, Charlie Cote, Ruby Wasti, Mohanapriya Kamalakannan, Astrid Jeschko, Gabriela Melo-Zainzinger, Angela Mcnabola, Varenka Rodriguez Rodriguez DiBlasi, Joseph Tumang, Ulrike Tontsch-Grunt, Melanie Hinkel, Jeanine Pignatelli, Francesca Trapani, Sandra Martinez-Morilla, Kaja Kostyrko, Marco H Hofmann, Abhishek Kashyap, Emilio Flano, Kang Liu
Publikováno v:
Cancer Immunology Research. 10:B23-B23
KRAS is most frequently mutated in pancreatic adenocarcinomas (PDAC) with more than 90% of cases having a KRAS mutation. This leads to constitutive activation of the downstream signaling pathways, driving tumor cell proliferation whilst co-opting the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::23cdb26903f70506c8f0e4a9e01950f7
https://doi.org/10.1158/2326-6074.tumimm22-b23
https://doi.org/10.1158/2326-6074.tumimm22-b23
Autor:
Mark Love
Publikováno v:
Forensic Update. 1:5-6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::88ee804008d2caa2a3612caedd8dd0e5
https://doi.org/10.53841/bpsfu.2021.1.139.5
https://doi.org/10.53841/bpsfu.2021.1.139.5
Autor:
Anthony P. McHale, Mark Love, Darren M. Griffith, John F. Callan, Thomas McKaig, Keiran Logan, Jinhui Gao, Mark A. Taylor, Heather Nesbitt, Bridgeen Callan
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society. 338
FOLFIRINOX and FOLFOXIRI are combination chemotherapy treatments that incorporate the same drug cocktail (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) but exploit an altered dosing regimen when used in the management of pancreatic and co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04989e29d4a4b9cc16c92a55225230be
https://pubmed.ncbi.nlm.nih.gov/34481018
https://pubmed.ncbi.nlm.nih.gov/34481018
Autor:
Anthony P. McHale, Eleanor Stride, Jinhui Gao, Keith Thomas, John F. Callan, Mark A. Taylor, Mark Love, Bridgeen Callan, Keiran Logan, Thomas McKaig, Heather Nesbitt
Publikováno v:
Cancer letters. 517
The emergence of immune checkpoint inhibitors (ICI's) in the past decade has proven transformative in the area of immuno-oncology. The PD-1/PD-L1 axis has been particularly well studied and monoclonal antibodies developed to block either the receptor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e751cd924149ef010ad628bc2fa7dc6c
https://pubmed.ncbi.nlm.nih.gov/34119606
https://pubmed.ncbi.nlm.nih.gov/34119606